CBRE Group
CBRE
$140.65
-2.37%
CBRE Group, Inc. is the world's largest commercial real estate services and investment firm, providing a comprehensive suite of services including leasing, property and project management, capital markets advisory, and investment management. The company is a dominant global market leader in its industry, distinguished by its extensive scale, integrated service platform, and its investment management arm, which managed over $155 billion in client assets as of year-end 2025. The current investor narrative is dominated by the stock's sharp reaction to broader market volatility and AI-driven sector rotations in early 2026, as highlighted in recent news, which has created a debate around whether the sell-off presents a long-term opportunity or reflects deeper cyclical pressures in the real estate services sector.…
CBRE
CBRE Group
$140.65
CBRE 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on CBRE Group's 12-month outlook, with a consensus price target around $182.85 and implied upside of +30.0% versus the current price.
Average Target
$182.85
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$113 - $183
Analyst target range
Insufficient analyst coverage available. The provided data indicates only two analysts are contributing to the estimates, which is minimal for a company of CBRE's market cap. This limited coverage can lead to higher stock price volatility and less efficient price discovery, as institutional sentiment is not broadly gauged. The available data shows an average EPS estimate of $13.35 for an unspecified period, with a range from $12.14 to $14.70, but without a consensus price target or recommendation distribution, a meaningful analysis of analyst sentiment cannot be performed. The recent institutional ratings from firms like Barclays (Overweight), UBS (Buy), and KBW (Outperform) suggest a bullish tilt among the few covering analysts, but the overall picture remains one of under-coverage relative to the company's size and prominence.
Bulls vs Bears: CBRE Investment Factors
The bull and bear cases for CBRE are sharply divided, with the bear side currently holding stronger evidence due to concrete, negative price action and deteriorating fundamentals. The bull thesis rests on the company's dominant scale, strong revenue growth, and a seemingly reasonable forward P/E of 16x. However, the bear case is reinforced by severe margin compression, an elevated trailing valuation that expanded during a price decline, and clear technical breakdown. The single most important tension in the investment debate is whether the sharp gross margin decline in Q4 2025 (15.29% vs. 19.40% in Q3) is a one-time anomaly or the beginning of a sustained profitability downturn. The resolution of this margin pressure will determine if the company can grow into its forward earnings estimates and justify a valuation re-rating, or if earnings will disappoint, leading to further multiple compression.
Bullish
- Strong Revenue Growth Trajectory: Q4 2025 revenue grew 11.77% YoY to $11.63B, and quarterly revenue accelerated sequentially from $8.91B in Q1 to $11.63B in Q4. This demonstrates robust underlying business momentum despite market volatility.
- Significant Free Cash Flow Generation: The company generated $1.19B in trailing twelve-month free cash flow, providing strong internal funding capacity for investments, acquisitions, or shareholder returns. This financial flexibility is a key strength for a market leader.
- Attractive Forward Valuation: The forward P/E ratio of 16.0x is significantly lower than the trailing P/E of 41.44x, indicating the market expects a substantial earnings recovery. This forward multiple presents a more reasonable entry point if earnings estimates are met.
- Dominant Market Position & Scale: As the world's largest commercial real estate services firm with an investment management arm overseeing over $155B in client assets, CBRE benefits from unmatched scale and an integrated platform, creating significant competitive moats.
Bearish
- Severe Profitability Pressure: Q4 2025 gross margin collapsed to 15.29% from 19.40% in Q3 2025 and 20.66% in Q4 2024. This sharp sequential and annual decline signals significant cost pressures or unfavorable revenue mix shifts, directly impacting earnings quality.
- Elevated & Expanding Trailing Valuation: The trailing P/E of 41.44x is high and represents a significant expansion from 28.69x at the end of Q4 2025. With a PEG ratio of 1.82, the stock is not cheap relative to its growth, posing a risk of multiple compression.
- Pronounced Technical Downtrend & Underperformance: The stock is down 16.74% over 3 months and has underperformed the SPY by 20.88% in that period, breaking decisively from its 52-week high. With a beta of 1.35, this downside volatility is amplified, and key support at $118.81 is 16% below the current price.
- Leveraged Balance Sheet: A debt-to-equity ratio of 1.13 indicates a leveraged financial structure. While manageable with strong cash flow, it increases financial risk and interest expense sensitivity in a higher-rate environment, as seen with $27M interest expense in Q4.
CBRE Technical Analysis
The stock is in a pronounced downtrend, having declined 16.74% over the past three months and 6.97% over six months, despite a positive 14.81% gain over the past year. The current price of $141.81 sits approximately 19% above its 52-week low of $118.81 but 19% below its 52-week high of $174.27, positioning it in the lower-middle portion of its annual range, suggesting the momentum from earlier highs has been decisively broken. Recent short-term momentum shows a modest 5.44% gain over the past month, which diverges positively from the steeper three-month decline, hinting at a potential stabilization or relief rally attempt. However, the stock's relative strength metrics are deeply negative, with a 1-month relative strength of -4.54% and a 3-month figure of -20.88%, indicating it has significantly underperformed the broader market (SPY) during this period. Key technical support is clearly defined at the 52-week low of $118.81, while resistance is at the recent high of $174.27; a sustained breakdown below support would signal a continuation of the bearish trend, while reclaiming the $170 level would be necessary to suggest a reversal. With a beta of 1.35, CBRE is approximately 35% more volatile than the SPY, which amplifies both downside risk and potential upside during market recoveries, a critical factor for risk-adjusted positioning.
Beta
1.28
1.28x market volatility
Max Drawdown
-23.2%
Largest decline past year
52-Week Range
$119-$174
Price range past year
Annual Return
+7.1%
Cumulative gain past year
| Period | CBRE Return | S&P 500 |
|---|---|---|
| 1m | -3.6% | +8.2% |
| 3m | +3.2% | +9.0% |
| 6m | -8.5% | +10.5% |
| 1y | +7.1% | +26.5% |
| ytd | -12.2% | +8.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CBRE Fundamental Analysis
Revenue growth remains positive but has shown volatility on a quarterly basis; the most recent Q4 2025 revenue was $11.63 billion, representing a solid 11.77% year-over-year increase. However, examining the sequential quarterly revenue from Q1 to Q4 2025 ($8.91B, $9.75B, $10.26B, $11.63B) reveals an accelerating growth trend through the year, which is a constructive sign for the underlying business momentum. The company is profitable, with Q4 2025 net income of $416 million, translating to a net margin of 3.58%. Profitability metrics, however, show pressure: the gross margin for Q4 2025 was 15.29%, a sequential decline from the 19.40% gross margin in Q3 2025, indicating potential cost pressures or revenue mix shifts. The balance sheet and cash flow position is mixed; the company generated substantial trailing twelve-month free cash flow of $1.19 billion, providing strong internal funding capacity. However, the debt-to-equity ratio of 1.13 indicates a leveraged balance sheet, and the current ratio of 1.09 suggests adequate but not robust short-term liquidity. Return on equity (ROE) stands at a respectable 13.03%, demonstrating efficient use of shareholder capital, but this is supported by the aforementioned financial leverage.
Quarterly Revenue
$11.6B
2025-12
Revenue YoY Growth
+0.11%
YoY Comparison
Gross Margin
+0.15%
Latest Quarter
Free Cash Flow
$1.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CBRE Overvalued?
Given the positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is elevated at 41.44x, while the forward PE is significantly lower at 16.00x, indicating the market expects a substantial recovery in earnings over the next twelve months. Compared to sector averages (data not explicitly provided in the input), the high trailing multiple suggests a premium, but the forward multiple would likely be more in line if earnings estimates are met. The stock's current valuation is high relative to its own recent history; the historical ratios show the PE ratio at the end of Q4 2025 was 28.69x, meaning the current trailing PE of 41.44x represents a significant expansion, placing it near the top of its recent valuation band. This elevated multiple, despite the recent price decline, suggests the market is still pricing in optimistic long-term earnings growth or that recent earnings have been depressed, creating a higher multiple on a depressed base. The PEG ratio of 1.82, based on trailing metrics, indicates the stock is not cheap relative to its growth rate.
PE
41.4x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 12x~75x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
21.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are centered on profitability and leverage. The gross margin collapse from 19.40% to 15.29% sequentially is a severe red flag, indicating potential unsustainable cost structures or a shift to lower-margin business lines. The debt-to-equity ratio of 1.13 signifies a leveraged balance sheet, which, combined with a current ratio of just 1.09, limits financial flexibility. While strong TTM FCF of $1.19B provides a buffer, earnings volatility is high, with Q4 2025 net income of $416M down from $487M in Q4 2024, creating uncertainty around the forward P/E's foundation.
Market & Competitive Risks are pronounced given the stock's reaction to broader trends. The stock's beta of 1.35 means it is 35% more volatile than the market, amplifying downside during sector rotations like the AI-driven sell-off highlighted in recent news. Trading at a trailing P/E of 41.44x—a significant expansion from its recent 28.69x—creates substantial valuation compression risk if growth expectations falter. Furthermore, as a commercial real estate services firm, CBRE is highly sensitive to macroeconomic cycles, interest rates, and property market health, with recent underperformance (-20.88% vs. SPY over 3 months) signaling investor concern over these cyclical pressures.
The Worst-Case Scenario involves a continuation of the margin erosion combined with a broader economic slowdown that reduces transaction volumes in commercial real estate. This could lead to a double miss on both revenues and earnings, triggering analyst downgrades and a full valuation de-rating. The specific chain of events would be: Q2 2026 gross margins fail to recover, forward EPS estimates of $13.35 are cut, and the forward P/E compresses toward 12x. This could realistically drive the stock back to its 52-week low of $118.81, representing a downside of approximately -16% from the current price of $141.81. A breach of that support could lead to further losses, potentially matching the stock's maximum drawdown of -23.22% experienced recently.